263 related articles for article (PubMed ID: 8624132)
1. Amyloid fibril toxicity in Alzheimer's disease and diabetes.
Lorenzo A; Yankner BA
Ann N Y Acad Sci; 1996 Jan; 777():89-95. PubMed ID: 8624132
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo A; Yankner BA
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12243-7. PubMed ID: 7991613
[TBL] [Abstract][Full Text] [Related]
3. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.
Milton NG; Harris JR
Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213
[TBL] [Abstract][Full Text] [Related]
4. Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones.
Burgevin MC; Passat M; Daniel N; Capet M; Doble A
Neuroreport; 1994 Dec; 5(18):2429-32. PubMed ID: 7696573
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.
Lorenzo A; Razzaboni B; Weir GC; Yankner BA
Nature; 1994 Apr; 368(6473):756-60. PubMed ID: 8152488
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
Jaikaran ET; Clark A
Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
[TBL] [Abstract][Full Text] [Related]
7. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F
J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815
[TBL] [Abstract][Full Text] [Related]
9. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.
Aitken JF; Loomes KM; Konarkowska B; Cooper GJ
Biochem J; 2003 Sep; 374(Pt 3):779-84. PubMed ID: 12812521
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity.
May PC; Boggs LN; Fuson KS
J Neurochem; 1993 Dec; 61(6):2330-3. PubMed ID: 8245987
[TBL] [Abstract][Full Text] [Related]
11. Effects of Amylin Against Amyloid-β-Induced Tauopathy and Synapse Loss in Primary Neurons.
Gan Q; Yao H; Na H; Ballance H; Tao Q; Leung L; Tian H; Zhu H; Wolozin B; Qiu WQ
J Alzheimers Dis; 2019; 70(4):1025-1040. PubMed ID: 31306122
[TBL] [Abstract][Full Text] [Related]
12. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
[TBL] [Abstract][Full Text] [Related]
13. [Amyloidogenic peptides such as beta-amyloid, amylin and calcitonin strongly enhance the susceptibility of rat hippocampal neurons to excitatory amino acids in vivo].
Morimoto K; Nagata S; Kubo T; Oda T; Kaneko I
Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():83P-87P. PubMed ID: 10190140
[TBL] [Abstract][Full Text] [Related]
14. The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design.
Akter R; Zhyvoloup A; Zheng B; Bhatia SR; Raleigh DP
PLoS One; 2019; 14(8):e0219130. PubMed ID: 31404073
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid peptides 1-40betaA and 25-35betaA suppress human amylin-mediated death of RINm5F islet beta-cells with distinct actions on fibril formation.
Bai JZ
Cell Biol Int; 2008 Apr; 32(4):447-55. PubMed ID: 18291688
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
17. Full-length rat amylin forms fibrils following substitution of single residues from human amylin.
Green J; Goldsbury C; Mini T; Sunderji S; Frey P; Kistler J; Cooper G; Aebi U
J Mol Biol; 2003 Feb; 326(4):1147-56. PubMed ID: 12589759
[TBL] [Abstract][Full Text] [Related]
18. Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation.
Green JD; Goldsbury C; Kistler J; Cooper GJ; Aebi U
J Biol Chem; 2004 Mar; 279(13):12206-12. PubMed ID: 14704152
[TBL] [Abstract][Full Text] [Related]
19. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
